CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.
about
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypesDifferential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypesDefining the fitness of HIV-1 isolates with dual/mixed co-receptor usageThe origin and evolutionary history of HIV-1 subtype C in SenegalRestricted genetic diversity of HIV-1 subtype C envelope glycoprotein from perinatally infected Zambian infants.Functional conservation and coherence of HIV-1 subtype A Vpu alleles.High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C virusesFunctional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmissionThe Influence of HIV on the Evolution of Mycobacterium tuberculosis.HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.Genetic characterization of human immunodeficiency virus type 1 transmission in the Middle East and North AfricaEvolution and molecular epidemiology of subtype C HIV-1 in ZimbabweVariation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parametersHIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form.Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progressionDistinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort studyLongitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection.Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China.Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina.Involvement of a C-terminal motif in the interference of primate lentiviral Vpu proteins with CD1d-mediated antigen presentation.Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period.Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity.Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness.Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection.Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress.Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc.Viral Decay Dynamics and Mathematical Modeling of Treatment Response: Evidence of Lower in vivo Fitness of HIV-1 Subtype CPartial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART.Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.Increasing heterosexual transmission of HIV-1 subtype C in Inland Central Western Brazil.HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa.Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.
P2860
Q21245213-71789BF9-56CF-472D-B136-F454FE0101E0Q24612992-722AEBB1-F769-4D3E-ABF1-D9A594FB7ADAQ30278577-8B3D5E82-162D-4495-B19F-5B0B62DEF262Q30414915-9BEBBBDC-D6FD-4528-AFC3-348B44DBD045Q33533351-6C1DE949-3F05-452C-B56E-4C557E2FECDBQ33670199-5063D76B-8093-4A13-891B-E4FA29A91B64Q33736978-6BFE95FD-7A52-4DEF-ADF3-D2504C715EFAQ33749206-8CD8E5BF-0BC7-462D-9C69-720456A079E3Q33757201-B4F50044-9D25-44BD-9C66-649E9450F39AQ33874874-FC1BF3F6-60BB-44AF-9FB9-3221CB113EACQ33897090-90561051-3023-434E-B395-37A07FBDFB1EQ34073190-D84D5EEB-4078-418D-A8E8-3213B5F5DDBEQ34170655-F3EB4A47-7740-4FA2-86FE-2D853423F10EQ34178349-9AAE3FDF-83FB-410B-95FE-2157EFFFB523Q34243456-158AEA64-2C10-4E27-86AD-BE8C8B5069C1Q34243467-156986F2-8C3A-4EBC-8B8F-505A772A8BFBQ34350944-1728F205-A7BB-45B0-BC09-0AB502951596Q34503200-A023DE68-802D-4FA8-923B-40ED7D1822C5Q34609382-E5720840-88EA-44D9-A2E0-D6FDB4E188D5Q34792976-D4975E5C-2008-4A78-BDB0-E87460E4DE5CQ35107377-7A354BB6-9CA9-460E-8D1E-B68B9D7D3C2FQ35146589-823AE5D3-0C89-4DB8-9691-8473C899726FQ35424048-0A7DBBCD-3C5A-4792-A927-C6217CDB3550Q35827900-D7DE19C8-B938-4244-AD04-A84AE5EAF64CQ35993707-04F45BC7-EA9B-4F8E-9A06-D7015D0DD9E1Q36124813-E5A1E57D-6597-4EE9-B1B7-BE08C74F69A5Q36171647-EDB84B0E-45DE-4E52-A8B7-0C0BFE5C3667Q36394656-27FA83FA-177D-4EF0-9F49-3D732B7F530BQ36414578-FAF63D4A-C88F-43AC-8EA0-132C61C4E2CFQ36530346-DF6219FD-A5EC-44B5-8AEA-A55209EF3BEBQ36978615-F9A3E11D-4864-486C-90F7-02AD109CADF1Q37141248-9F6980EC-9D31-4BA9-9BB6-EA9DE0BAD149Q37390786-55205946-A271-41D8-82DA-26863B4A0A6BQ37519818-96F964FE-3078-41FF-9E89-FDAA9817837DQ37642937-8BD9B9C2-5546-4A69-B099-35F46973C323Q38659318-C1807AD1-9F62-48C1-A50E-F6299593A0B8Q38706845-330FD466-6E65-4DD0-AACB-6538B38A9813Q38867834-47A66FEA-5632-44D8-B020-A0566CEED9C4Q39410515-A215C3FF-15FF-4C56-A4D5-38E1D79BBE36Q39808350-23422A97-1EEC-4C05-87D6-AA6F7DF49AE7
P2860
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CCR5- and CXCR4-tropic subtype ...... implications for the epidemic.
@en
CCR5- and CXCR4-tropic subtype ...... implications for the epidemic.
@nl
type
label
CCR5- and CXCR4-tropic subtype ...... implications for the epidemic.
@en
CCR5- and CXCR4-tropic subtype ...... implications for the epidemic.
@nl
prefLabel
CCR5- and CXCR4-tropic subtype ...... implications for the epidemic.
@en
CCR5- and CXCR4-tropic subtype ...... implications for the epidemic.
@nl
P2093
P2860
P356
P1433
P1476
CCR5- and CXCR4-tropic subtype ...... implications for the epidemic.
@en
P2093
Asna Siddiqui
Awet Abraha
Carolina Herrera
David Katzenstein
Denis M Tebit
Elizabeth Johnston
Eric J Arts
Immaculate L Nankya
Korey Demers
Lucia Fischetti
P2860
P304
P356
10.1128/JVI.02051-08
P407
P577
2009-03-18T00:00:00Z